🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Sponsor trial record
Trackers Companies Trial finder
Sponsor · clinical trials

Perspectum clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our UK and USA registers with Perspectum as lead sponsor. Synced 26 Sep 2026
7Current trials
4Recruiting now
0Drugs in these trials
2Trial registers
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist
Compiled from ClinicalTrials.gov and CTIS registry records · Last verified · Editorial standards
At a glance

Perspectum is the lead sponsor of 7 current clinical trials in our UK and USA registers. 4 are recruiting patients now. The most common phase is Observational. The most-studied condition is Type2 Diabetes.

ClinicalTrials.gov trials by status

  • Recruiting457%
  • Active, closed343%

Trials by phase

  • Observational686%
  • Not applicable114%
01

Clinical trials sponsored by Perspectum

7 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
UK Imaging Diabetes Study Seeing Diabetes Clearly
NCT05057403 · Type2 Diabetes
Observational Recruiting 2022-05 UK
Haemdall: Developing a Quantitative MRI Biomarker of Infratentorial Superficial Siderosis of the Central Nervous System
NCT07098650 · Superficial Siderosis
Observational Recruiting 2025-08 UK
Research and Development of Novel Quantitative Magnetic Resonance Imaging (MRI) Techniques in a Single Scan for Multiple Organ Application
NCT05110248 · ClinicalTrials.gov ↗ · Multiple
Observational Recruiting 2021-11 UK
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
NCT04054310 · ClinicalTrials.gov ↗ · NASH - Nonalcoholic Steatohepatitis
Not applicable Recruiting 2020-08 USA
Longitudinal Assessment of Multiple Organs in Patients With Type 2 Diabetes
NCT04114682 · ClinicalTrials.gov ↗ · Type 2 Diabetes
Observational Active, closed 2020-01 UK
West Hertfordshire Inflammatory Bowel Disease Technology Study
NCT05000242 · ClinicalTrials.gov ↗ · Inflammatory Bowel Diseases
Observational Active, closed 2022-01 UK
Contrast-Free Magnetic Resonance Imaging for Breast Disease
NCT05006196 · ClinicalTrials.gov ↗ · Breast Cancer, Breast Diseases
Observational Active, closed 2021-07 UK

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in Perspectum trials

8 conditions
Type2 Diabetes1Superficial Siderosis1Type 2 Diabetes1Multiple1Inflammatory Bowel Diseases1Breast Cancer1Breast Diseases1NASH - Nonalcoholic Steatohepatitis1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in UK63
Clinical trials in USA11

A trial with sites in more than one country appears in each of those registers.

04

Questions about Perspectum trials

How many clinical trials does Perspectum sponsor?

Perspectum is the lead sponsor of 7 current trials on ClinicalTrials.gov in our UK and USA registers, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are Perspectum trials recruiting?

Yes. 4 of its 7 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.